Investor Presentaiton slide image

Investor Presentaiton

Results in Overview Transaction Value ↑ 26.4% Gross Profit ↑ 28.1% EBITDA ↑ 424.0% Operating Leverage Achieved STATUTORY NORMALISED¹ STATUTORY FY21 $'000 FY21 $'000 FY20 $'000 GROWTH - NORMALISED FY21 TO FY20 % Payments Business Performance (normalised¹) FY21 $'000 FY20 $'000 GROWTH % Transaction value 25,453,507 20,131,045 26.4% Transaction value Payments revenue and income Lending and investment income 25,453,507 25,453,507 20,131,045 A 26.4% Revenue 230,204 202,826 13.5% Other revenue and income Revenue Less: Direct expenses Gross profit Less: Operating expenses (excl. share-based payments) EBITDA2 229,221 3,222 6,079 238,522 (119,073) 119,449 (122,551) (105,568) 230,204 3,222 202,826 13.5% Gross profit 110,812 86,142 28.6% 1,818 77.2% Banking Business FY21 FY20 GROWTH 6,079 6,031 0.8% Performance $'000 $'000 % 239,505 210,675 13.7% Revenue 3,222 1,818 77.2% (119,771) (117,200) 119,734 93,475 (97,847) 2.2% 28.1% Gross Profit 2,843 1,302 118.4% Operating expenses (excl. share-based payments) - % of gross profit (normalised¹) 7.9% (3,102) 14,166 (4,372) 424.0% Less: Share-based payments expense IPO costs (9,342) (8,779) (10,896) 19.4% 116.4% 114.2% 110.3% 104.7% 96.1% (331) (9,730) 96.6% 88.2% Share of loss from associates (1,119) (1,119) Depreciation & Amortisation (15,364) (15,364) (12,524) 22.7% Bendigo Bank partner revenue share 698 EBIT (29,258) (10,398) (37,522) 72.3% Less: Net interest expense Loss before tax (517) (29,775) (517) (535) 3.4% (10,915) (38,057) 71.3% Normalised results are adjusted for the costs associated with the terminal connectivity issue and M&A activity. Refer to page 29 for a reconciliation of normalised results to statutory results. Tyro uses EBITDA as a non-IFRS measure of business performance, which excludes the non-cash impact of share-based payments expense, share of loss from associates, expenses associated with the terminal connectivity issue and the IPO and other significant one-off costs. Refer to the page 29 for a reconciliation of normalised results to statutory results. FY16 FY17 FY18 FY19 FY20 FY21 2 6
View entire presentation